Core Viewpoint - The company has decided to cancel its supervisory board and amend its articles of association due to the disqualification of six incentive targets from the 2021 restricted stock incentive plan, leading to the repurchase and cancellation of 20,000 unvested restricted shares [1]. Group 1 - The company held its eighth meeting of the fifth board of directors on April 28, 2025, where the proposal to cancel the supervisory board was approved [1]. - The total share capital of the company will decrease from 339,898,336 shares to 339,878,336 shares, and the registered capital will change from 339,898,336 yuan to 339,878,336 yuan [1]. - The company has completed the business registration change and obtained a new business license from the Qingdao Administrative Approval Service Bureau [1]. Group 2 - The company is classified as a listed other joint-stock company, with its registered address in the Chengdong Industrial Park, Chengyang District, Qingdao [1]. - The company was established on December 1, 1999, and its business scope includes the production and sale of water-soluble fertilizers and pesticides, as well as various other services related to agriculture and technology [1].
海利尔药业集团股份有限公司关于公司完成工商变更登记并换发营业执照的公告